Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAC-DRTB in Ethiopia
PACTR202603543990411Recruiting
- Sponsor
- Jimma University
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bedaquiline, pretomanid, linezolid and moxifloxacin in Tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB), sponsored by Jimma University. Started Feb 2026; status: recruiting.
02
Drugs
bedaquilinepretomanidlinezolidmoxifloxacin
03
Conditions
Tuberculosis (TB)multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on PACTR202603543990411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603543990411.